Li W, Li Y, Wang L, Yang M, Iikubo M, Huang N
Eur Radiol. 2025; .
PMID: 40042648
DOI: 10.1007/s00330-025-11473-9.
Pesapane F, Rotili A, Scalco E, Pupo D, Carriero S, Corso F
Radiol Med. 2025; .
PMID: 39992329
DOI: 10.1007/s11547-025-01969-1.
Duenweg S, Bobholz S, Lowman A, Winiarz A, Nath B, Barrett M
Front Oncol. 2025; 15:1433444.
PMID: 39990680
PMC: 11842255.
DOI: 10.3389/fonc.2025.1433444.
Leone A, Di Napoli V, Fochi N, Di Perna G, Spetzger U, Filimonova E
Diagnostics (Basel). 2025; 15(3).
PMID: 39941181
PMC: 11816478.
DOI: 10.3390/diagnostics15030251.
Li Y, Li W, Xiao H, Chen W, Lu J, Huang N
Clin Oral Investig. 2024; 29(1):25.
PMID: 39708187
DOI: 10.1007/s00784-024-06110-6.
Impact of intensity standardisation and ComBat batch size on clinical-radiomic prognostic models performance in a multi-centre study of patients with glioblastoma.
Fatania K, Frood R, Mistry H, Short S, OConnor J, Scarsbrook A
Eur Radiol. 2024; .
PMID: 39607450
DOI: 10.1007/s00330-024-11168-7.
Sex differences in brain MRI using deep learning toward fairer healthcare outcomes.
Dibaji M, Ospel J, Souza R, Bento M
Front Comput Neurosci. 2024; 18:1452457.
PMID: 39606583
PMC: 11598355.
DOI: 10.3389/fncom.2024.1452457.
Prediction of therapeutic response to transarterial chemoembolization plus systemic therapy regimen in hepatocellular carcinoma using pretreatment contrast-enhanced MRI based habitat analysis and Crossformer model.
Zhu Y, Liu T, Chen J, Wen L, Zhang J, Zheng D
Abdom Radiol (NY). 2024; .
PMID: 39586897
DOI: 10.1007/s00261-024-04709-7.
Prediction of tumor response to neoadjuvant chemotherapy in high-grade osteosarcoma using clustering-based analysis of magnetic resonance imaging: an exploratory study.
Benvenuti G, Marzi S, Vidiri A, Baldi J, Ceddia S, Riva F
Radiol Med. 2024; 130(1):13-24.
PMID: 39528860
DOI: 10.1007/s11547-024-01921-9.
Deep Learning-Based Synthetic Computed Tomography for Low-Field Brain Magnetic Resonance-Guided Radiation Therapy.
Yan Y, Kim J, Nejad-Davarani S, Dong M, Hurst Jr N, Zhao J
Int J Radiat Oncol Biol Phys. 2024; 121(3):832-843.
PMID: 39357787
PMC: 11875202.
DOI: 10.1016/j.ijrobp.2024.09.046.
An updated overview of radiomics-based artificial intelligence (AI) methods in breast cancer screening and diagnosis.
Elahi R, Nazari M
Radiol Phys Technol. 2024; 17(4):795-818.
PMID: 39285146
DOI: 10.1007/s12194-024-00842-6.
Radiogenomic profiling of global DNA methylation associated with molecular phenotypes and immune features in glioma.
Zhuang Z, Lin J, Wan Z, Weng J, Yuan Z, Xie Y
BMC Med. 2024; 22(1):352.
PMID: 39218882
PMC: 11367996.
DOI: 10.1186/s12916-024-03573-y.
Intratumoral habitat radiomics based on magnetic resonance imaging for preoperative prediction treatment response to neoadjuvant chemotherapy in nasopharyngeal carcinoma.
Zhu Y, Zheng D, Xu S, Chen J, Wen L, Zhang Z
Jpn J Radiol. 2024; 42(12):1413-1424.
PMID: 39162780
DOI: 10.1007/s11604-024-01639-8.
Dynamic Expansion and Contraction of Multiple Sclerosis T2-Weighted Hyperintense Lesions Are Present below the Threshold of Visual Perception.
Okuda D, Moog T, McCreary M, Shan K, Zubkow K, Newton B
AJNR Am J Neuroradiol. 2024; 46(2):443-450.
PMID: 39151959
PMC: 11878956.
DOI: 10.3174/ajnr.A8453.
Detection of diffusely abnormal white matter in multiple sclerosis on multiparametric brain MRI using semi-supervised deep learning.
Musall B, Gabr R, Yang Y, Kamali A, Lincoln J, Jacobs M
Sci Rep. 2024; 14(1):17157.
PMID: 39060426
PMC: 11282266.
DOI: 10.1038/s41598-024-67722-2.
Post-acquisition standardization of positron emission tomography images.
Mortazi A, Udupa J, Odhner D, Tong Y, Torigian D
Front Nucl Med. 2024; 3.
PMID: 39015756
PMC: 11251705.
DOI: 10.3389/fnume.2023.1210931.
Diffusion model enables quantitative CBF analysis of Alzheimer's Disease.
Shou Q, Cen S, Chen N, Ringman J, Wen J, Kim H
medRxiv. 2024; .
PMID: 39006427
PMC: 11245071.
DOI: 10.1101/2024.07.01.24309791.
Preoperative prediction of high-grade osteosarcoma response to neoadjuvant therapy based on a plain CT radiomics model: A dual-center study.
Yang F, Feng Y, Sun P, Traverso A, Dekker A, Zhang B
J Bone Oncol. 2024; 47:100614.
PMID: 38975332
PMC: 11225658.
DOI: 10.1016/j.jbo.2024.100614.
Integrating lipid metabolite analysis with MRI-based transformer and radiomics for early and late stage prediction of oral squamous cell carcinoma.
Li W, Li Y, Gao S, Huang N, Kojima I, Kusama T
BMC Cancer. 2024; 24(1):795.
PMID: 38961418
PMC: 11221018.
DOI: 10.1186/s12885-024-12533-x.
MRI-based radiomic features of the urinary bladder wall identify patients with moderate-to-severe international prostate symptom score.
Shahait M, Usamentiaga R, Tong Y, Sandberg A, Lee D, Udupa J
World J Urol. 2024; 42(1):375.
PMID: 38872048
PMC: 11176201.
DOI: 10.1007/s00345-024-05081-3.